| Official Gene Symbol | Other Aliases |
|---|---|
| XPNPEP1 | XPNPEPL, XPNPEPL1 |
| Sequence Length (AA) | Molecular Weight (Da) |
|---|---|
| 623 | 69918 |
| Protein Name |
|---|
| Xaa-Pro aminopeptidase 1 |
| Sources | |
|---|---|
|
UniProt PhosphoSitePlus ® GeneCards |
Human Protein Atlas |
| 10 | 20 | 30 | 40 | 50 |
| MPPKVTSELL | RQLRQAMRNS | EYVTEPIQAY | IIPSGDAHQS | EYIAPCDCRR |
| 60 | 70 | 80 | 90 | 100 |
| AFVSGFDGSA | GTAIITEEHA | AMWTDGRYFL | QAAKQMDSNW | TLMKMGLKDT |
| 110 | 120 | 130 | 140 | 150 |
| PTQEDWLVSV | LPEGSRVGVD | PLIIPTDYWK | KMAKVLRSAG | HHLIPVKENL |
| 160 | 170 | 180 | 190 | 200 |
| VDKIWTDRPE | RPCKPLLTLG | LDYTGISWKD | KVADLRLKMA | ERNVMWFVVT |
| 210 | 220 | 230 | 240 | 250 |
| ALDEIAWLFN | LRGSDVEHNP | VFFSYAIIGL | ETIMLFIDGD | RIDAPSVKEH |
| 260 | 270 | 280 | 290 | 300 |
| LLLDLGLEAE | YRIQVHPYKS | ILSELKALCA | DLSPREKVWV | SDKASYAVSE |
| 310 | 320 | 330 | 340 | 350 |
| TIPKDHRCCM | PYTPICIAKA | VKNSAESEGM | RRAHIKDAVA | LCELFNWLEK |
| 360 | 370 | 380 | 390 | 400 |
| EVPKGGVTEI | SAADKAEEFR | RQQADFVDLS | FPTISSTGPN | GAIIHYAPVP |
| 410 | 420 | 430 | 440 | 450 |
| ETNRTLSLDE | VYLIDSGAQY | KDGTTDVTRT | MHFGTPTAYE | KECFTYVLKG |
| 460 | 470 | 480 | 490 | 500 |
| HIAVSAAVFP | TGTKGHLLDS | FARSALWDSG | LDYLHGTGHG | VGSFLNVHEG |
| 510 | 520 | 530 | 540 | 550 |
| PCGISYKTFS | DEPLEAGMIV | TDEPGYYEDG | AFGIRIENVV | LVVPVKTKYN |
| 560 | 570 | 580 | 590 | 600 |
| FNNRGSLTFE | PLTLVPIQTK | MIDVDSLTDK | ECDWLNNYHL | TCRDVIGKEL |
| 610 | 620 | 623 | ||
| QKQGRQEALE | WLIRETQPIS | KQH |
Data source: UniProt
Uniprot Database Entry PhosphoSitePlus ®
loading
Data source: Panorama
View Details (opens in a new window)
Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614
Data source: Panorama
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
| Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
| y5 (1+) | 16.3 | 5.7 | 5.6 | 31.1 | 23.8 | 23 | 35.1 | 24.5 | 23.7 | 15 | 15 | 15 |
| y6 (1+) | 10.1 | 7.8 | 6.8 | 37.2 | 22.2 | 21.9 | 38.5 | 23.5 | 22.9 | 15 | 15 | 15 |
| y10 (1+) | 17.3 | 6.9 | 8.2 | 31.8 | 20.9 | 21.1 | 36.2 | 22 | 22.6 | 15 | 15 | 15 |
| sum | 13.7 | 5.3 | 5.5 | 30.9 | 22.2 | 22 | 33.8 | 22.8 | 22.7 | 15 | 15 | 15 |
Data source: Panorama
View Details (opens in a new window)
Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614
Data source: Panorama
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
| Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
| y7 (1+) | 34.2 | 18 | 14.6 | 37.5 | 27.1 | 29.5 | 50.8 | 32.5 | 32.9 | 15 | 15 | 15 |
| y8 (1+) | 34.5 | 23.2 | 18.9 | 50.8 | 27.6 | 27.9 | 61.4 | 36.1 | 33.7 | 15 | 15 | 15 |
| y10 (1+) | 46.3 | 15.4 | 10.3 | 32.5 | 30.6 | 28.1 | 56.6 | 34.3 | 29.9 | 15 | 15 | 15 |
| sum | 30.1 | 12.5 | 8.2 | 34.2 | 24.7 | 26.2 | 45.6 | 27.7 | 27.5 | 15 | 15 | 15 |
Comments